BargerTech International, LLC – Trademark Portfolio

Entity Type: 16

BargerTech International, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 40 (Treatment & Processing) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 0 trademarks are registered and 2 are pending. The owner is based in Findlay, OH.

1219 W. Main-Cross St., Ste. 100

Findlay, OH 45840

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

BargerTech International, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

40
Treatment & Processing (2 filings)

Treatment of materials

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does BargerTech International, LLC have?

BargerTech International, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 2 pending, 2 abandoned.

What trademark classes does BargerTech International, LLC file in?

BargerTech International, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 40 (Treatment & Processing), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 40 covers treatment of materials.

What is BargerTech International, LLC's trademark registration success rate?

BargerTech International, LLC has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 2 applications are pending review.